You'll make a lot more money if you know how to find and keep dividend payers in your portfolio.
Compare ABT Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
News & Analysis: Abbott Laboratories
These reliable businesses have delivered steadily growing profits to shareholders for decades, and they could keep it going indefinitely.
These stocks have each raised their payouts to shareholders for at least half of a century.
Advances in the core business highlight stable growth prospects.
Abbott Laboratories is a blue chip worth scooping up when it goes on sale.
These two businesses are stronger than ever, but their stock prices are at their lowest points in at least a year.
They're profitable, growing, hiking their payouts, and surviving the bear market without breaking a sweat.
Declines in the market make now the time to go bargain hunting.
Abbott generated strong growth in Q1 despite a significant drop in nutritional revenue.
There are more stormy waters ahead, but they might not be a problem in the end.